ClinConnect ClinConnect Logo
Search / Trial NCT05982808

CLIF Correction VS. Conventional Correction Strategy for ASD

Launched by SECOND AFFILIATED HOSPITAL, SCHOOL OF MEDICINE, ZHEJIANG UNIVERSITY · Aug 7, 2023

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Adult Spinal Deformity Clif Crenal Lumbar Interbody Fusion Minimal Invasive Correction Surgical Strategy

ClinConnect Summary

This clinical trial, called CLIF Correction VS. Conventional Correction Strategy for ASD, is looking at a new surgical technique for treating spinal deformities, specifically Adult Spinal Deformity (ASD). The goal is to see how this new method, known as CLIF correction, compares to traditional surgical approaches. Researchers will be studying how well each technique works, the results after surgery, and any complications that might occur. They will follow participants for two years to gather more information on how effective the CLIF correction is over time.

To participate in this trial, individuals must be adults aged between 40 and 80 years who have been diagnosed with a specific type of spinal deformity and have not found relief from other treatments. However, those with certain conditions, such as severe osteoporosis or previous spinal surgery, may not be eligible. Although the trial is not yet recruiting participants, it aims to provide valuable insights into which surgical method might be better for treating spinal deformities. If you or someone you know is considering surgery for spinal issues, this trial could be an important step in understanding the best options available.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • adult spinal deformtiy;
  • 40yrs≤age≤80yrs;
  • Lenke-Silva classification II-V grade;
  • ineffective with conservative treatment;
  • Exclusion Criteria:
  • severe osteoprosis with T value \<-2.5;
  • with preliminary spinal surgery;
  • ASA score≥III grade;
  • more than II degree spondylisthesis;
  • with mental disease;

About Second Affiliated Hospital, School Of Medicine, Zhejiang University

The Second Affiliated Hospital of Zhejiang University School of Medicine is a leading clinical research institution dedicated to advancing healthcare through innovative medical practices and rigorous scientific inquiry. With a robust infrastructure and a multidisciplinary team of experienced researchers and clinicians, the hospital is committed to conducting high-quality clinical trials that address critical health challenges. As an integral part of Zhejiang University, the hospital leverages academic expertise and cutting-edge technology to foster collaboration in research, education, and patient care, ultimately aiming to improve patient outcomes and contribute to the global medical community.

Locations

Hangzhou, Zhejiang, China

Patients applied

0 patients applied

Trial Officials

Zhi-wei WANG, Ph.D and MD.

Principal Investigator

2nd Hospital, Zhejiang University, School of Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported